CEREBRAL CANDIDIASIS

CEREBRAL CANDIDIASIS was reported 15 times

CEREBRAL CANDIDIASIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Asparagine-specific Enzyme [EPC] 10 0.0007
1 BCL-2 Inhibitor [EPC] 11 0.0002
2 SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] 1 0.0001
3 Nucleoside Metabolic Inhibitor [EPC] 11 0.0000
4 Folate Analog Metabolic Inhibitor [EPC] 11 0.0000
5 Corticosteroid [EPC] 13 0.0000
6 Azole Antifungal [EPC] 1 0.0000
7 Kinase Inhibitor [EPC] 1 0.0000